UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Manganese binding in rat bile

Archiv fü̈r Toxikologie, 1973-03, Vol.30 (3), p.227-236

1973

Volltextzugriff (PDF)

Analysis of the renal tissue of a woman chronically exposed to cadmium

International archives of occupational and environmental health, 1985-01, Vol.55 (3), p.241-246

1985

Volltextzugriff (PDF)

Changes in the binding of copper and zinc in the rat bile during 24 hours after application

Archives of toxicology, 1974-01, Vol.32 (4), p.321-329

1974

Volltextzugriff (PDF)

Comments on the mechanism of excretion of mercury compounds via bile in rats

Archives of toxicology, 1975-01, Vol.33 (3), p.267-271

1975

Volltextzugriff (PDF)

The effect of CdCl2 and AgNO3 pretreatment on the distribution of 110mAg+ in rat liver

Journal of hygiene, epidemiology, microbiology, and immunology, 1987, Vol.31 (3), p.245

1987

Volltextzugriff (PDF)

Effects of dosage and cadmium pretreatment on the binding of cadmium in rat bile

Experientia, 1979-12, Vol.35 (12), p.1640-1641

1979

Volltextzugriff (PDF)

The effect of 110mAg on ceruloplasmin oxidase activity in rats

Journal of hygiene, epidemiology, microbiology, and immunology, 1987, Vol.31 (1), p.39

1987

Volltextzugriff (PDF)

Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial

JAMA neurology, 2021-05, Vol.78 (5), p.558

2021

Volltextzugriff (PDF)

Binding of Cadmium and Mercury in the Rat Bile: Studies Using Gel Filtration

Acta pharmacologica et toxicologica, 1974-04, Vol.34 (4), p.246-253

1974

Volltextzugriff (PDF)

Biliary bilirubin in rats and exposure to metals

Journal of hygiene, epidemiology, microbiology, and immunology, 1982, Vol.26 (4), p.358

1982

Volltextzugriff (PDF)

Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement

Journal of neuroimmunology, 2021-08, Vol.357, p.577627-577627, Article 577627

2021

Volltextzugriff (PDF)

The study of exposure to cadmium in the general population. II. Morbidity studies

Polish journal of occupational medicine and environmental health, 1992, Vol.5 (4), p.345

1992

Volltextzugriff (PDF)

Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years

American journal of neuroradiology : AJNR, 2013-10, Vol.34 (10), p.1931-1939

2013

Volltextzugriff (PDF)

The gold standard of thyroid nodule examination? Prospective validation of the ACR TI-RADS in a secondary referral center

Physiological research, 2020-09, Vol.69 (Suppl 2), p.S329-S337

2020

Volltextzugriff (PDF)

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

The New England journal of medicine, 2010-02, Vol.362 (5), p.387-401

2010

Volltextzugriff (PDF)

Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study

Multiple sclerosis and related disorders, 2022-02, Vol.58, p.103404-103404, Article 103404

2022

Volltextzugriff (PDF)

Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial

Therapeutic advances in neurological disorders, 2021, Vol.14, p.1756286420982134-1756286420982134

2021

Volltextzugriff (PDF)

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

The Lancet (British edition), 2008-10, Vol.372 (9648), p.1463-1472

2008

Volltextzugriff (PDF)

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study

Multiple sclerosis, 2010-11, Vol.16 (11), p.1360-1366

2010

Volltextzugriff (PDF)

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

The New England journal of medicine, 2012-09, Vol.367 (12), p.1087-1097

2012

Volltextzugriff (PDF)

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

Multiple sclerosis, 2018-02, Vol.24 (2), p.96-120

2018

Volltextzugriff (PDF)

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Lancet neurology, 2012-05, Vol.11 (5), p.420-428

2012

Volltextzugriff (PDF)

Restless legs syndrome in Czech patients with multiple sclerosis: An epidemiological and genetic study

Sleep medicine, 2012-08, Vol.13 (7), p.848-851

2012

Volltextzugriff (PDF)

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

The New England journal of medicine, 2015-10, Vol.373 (15), p.1418-1428

2015

Volltextzugriff (PDF)

1 – 25 von 253

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(181)

Publikationsform

Artikel
(232)
Tagungsberichte
(21)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Life Sciences & Biomedicine
(140)
Humans
(132)
Multiple Sclerosis
(96)
Neurosciences & Neurology
(94)
Female
(93)
Clinical Neurology
(89)
Adult
(83)
Male
(80)
Middle Aged
(64)
Neurology
(58)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(51)
Neurosciences
(49)
Magnetic Resonance Imaging
(46)
Medicin Och Hälsovetenskap
(41)
Biological And Medical Sciences
(40)
Medical Sciences
(39)
Disease Progression
(36)
Treatment Outcome
(33)
Multiple Sclerosis - Drug Therapy
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Manganese binding in rat bile

Analysis of the renal tissue of a woman chronically exposed to cadmium

Changes in the binding of copper and zinc in the rat bile during 24 hours after application

Comments on the mechanism of excretion of mercury compounds via bile in rats

The effect of CdCl2 and AgNO3 pretreatment on the distribution of 110mAg+ in rat liver

Effects of dosage and cadmium pretreatment on the binding of cadmium in rat bile

The effect of 110mAg on ceruloplasmin oxidase activity in rats

Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial

Binding of Cadmium and Mercury in the Rat Bile: Studies Using Gel Filtration

Biliary bilirubin in rats and exposure to metals

Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement

The study of exposure to cadmium in the general population. II. Morbidity studies

Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years

The gold standard of thyroid nodule examination? Prospective validation of the ACR TI-RADS in a secondary referral center

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study

Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Restless legs syndrome in Czech patients with multiple sclerosis: An epidemiological and genetic study

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Suchergebnisse filtern